Literature DB >> 6251973

Structure and gene organization in the transformed Hind III-G fragment of Ad12.

H Sugisaki, K Sugimoto, M Takanami, K Shiroki, I Saito, H Shimojo, Y Sawada, Y Uemizu, S Uesugi, K Fujinaga.   

Abstract

The nucleotide sequence of the transforming Hind III-G fragment of Ad12 DNA which encompasses the left 6.8% of the genome has been determined. The fragment was 2320 nucleotides long, and contained a GC cluster at positions 126-155 and a region extremely rich in AT at positions 1098-1142 (number from the leftmost end). Possible coding regions for the two transforming gene products were assigned. The predicted coding region for T antigen g is positions 502-1069 and positions 1144-1373, which are joined by splicing (266 amino acid residues, 30 kd), and that for T antigen f is positions 1845-2126 (94 amino acid residues, 10 kd). The sequence of the Hind III-G fragment was compared with that of the transforming DNA fragment of Ad5 which encompasses the left 8.0% of the genome (2809 nucleotides). There are several discrete regions with significant sequence homology. The comparison suggests that the regions in the left two thirds of the Ad5 and Ad12 transforming DNA fragments (map units 0-4.7% in Ad5 and 0-4.4% in Ad12) bear some resemblance in their gene organizations, and code for proteins containing structurally homologous regions.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6251973     DOI: 10.1016/0092-8674(80)90324-4

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  43 in total

1.  E1A dependent up-regulation of c-jun/AP-1 activity.

Authors:  I Kitabayashi; R Chiu; G Gachelin; K Yokoyama
Journal:  Nucleic Acids Res       Date:  1991-02-11       Impact factor: 16.971

2.  Structure of viral DNA in a rat cell line transformed by the cloned EcoRI-C fragment of adenovirus 12.

Authors:  Y Kawarabayasi; H Sugisaki
Journal:  Nucleic Acids Res       Date:  1985-09-25       Impact factor: 16.971

3.  Identification of mouse adenovirus type 1 early region 1: DNA sequence and a conserved transactivating function.

Authors:  A O Ball; M E Williams; K R Spindler
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

4.  An insertion mutation in the adenovirus type 12 early region 1A 13S mRNA unique region.

Authors:  K Ohshima; K Shiroki
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

5.  Synthesis in Escherichia coli of human adenovirus type 12 transforming proteins encoded by early region 1A 13S mRNA and 12S mRNA.

Authors:  D Kimelman; L A Lucher; K H Brackmann; J S Symington; M Ptashne; M Green
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

6.  Identification of adenovirus 12-encoded E1A tumor antigens synthesized in infected and transformed mammalian cells and in Escherichia coli.

Authors:  L A Lucher; D Kimelman; J S Symington; K H Brackmann; M A Cartas; H Thornton; M Green
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

7.  Production of a monospecific antiserum against the early region 1A proteins of adenovirus 12 and adenovirus 5 by an adenovirus 12 early region 1A-beta-galactosidase fusion protein antigen expressed in bacteria.

Authors:  M O Scott; D Kimelman; D Norris; R P Ricciardi
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

8.  Expression of the chloramphenicol acetyltransferase gene in mammalian cells under the control of adenovirus type 12 promoters: effect of promoter methylation on gene expression.

Authors:  I Kruczek; W Doerfler
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

9.  Nucleotide sequence at the site of junction between adenovirus type 12 DNA and repetitive hamster cell DNA in transformed cell line CLAC1.

Authors:  S Stabel; W Doerfler
Journal:  Nucleic Acids Res       Date:  1982-12-20       Impact factor: 16.971

10.  Expression of adenovirus type 12 E1A gene in monkey cells, using a simian virus 40 vector.

Authors:  K Oda; H Kato; I Saito; S Sugano; K Maruyama; M Masuda; K Shiroki; H Shimojo
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.